Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Diabetes 56:57-64, 2007
DOI: 10.2337/db06-0517
© 2007 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online-Appendix Only
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vasavada, R. C.
Right arrow Articles by Stewart, A. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vasavada, R. C.
Right arrow Articles by Stewart, A. F.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Tissue-Specific Deletion of the Retinoblastoma Protein in the Pancreatic ß-Cell Has Limited Effects on ß-Cell Replication, Mass, and Function

Rupangi C. Vasavada, Irene Cozar-Castellano, Darinka Sipula, and Andrew F. Stewart

From the Division of Endocrinology, the University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania

Address correspondence and reprint requests to Rupangi C. Vasavada, PhD, Division of Endocrinology, BST E-1140, University of Pittsburgh School of Medicine, 200 Lothrop St., Pittsburgh, PA 15213. E-mail: vasavada{at}dom.pitt.edu

Key Words: BrdU, bromodeoxyuridine • RIP, rat insulin promoter

Animal studies show that G1/S regulatory molecules (D-cyclins, cdk-4, p18, p21, p27) are critical for normal regulation of ß-cell proliferation, mass, and function. The retinoblastoma protein, pRb, is positioned at the very end of a cascade of these regulatory proteins and is considered the final checkpoint molecule that maintains ß-cell cycle arrest. Logically, removal of pRb from the ß-cell should result in unrestrained ß-cell replication, increased ß-cell mass, and insulin-mediated hypoglycemia. Because global loss of both pRb alleles is embryonic lethal, this hypothesis has not been tested in ß-cells. We developed two types of conditional knockout (CKO) mice in which both alleles of the pRb gene were inactivated specifically in ß-cells. Surprisingly, although the pRb gene was efficiently recombined in ß-cells of both CKO models, changes in ß-cell mass, ß-cell replication rates, insulin concentrations, and blood glucose levels were limited or absent. Other pRb family members, p107 and p130, were not substantially upregulated. In contrast to dogma, the pRb protein is not essential to maintain cell cycle arrest in the pancreatic ß-cell. This may reflect fundamental inaccuracies in models of ß-cell cycle control or complementation for pRb by undefined proteins.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.